Login
$CSAI
$2.26 +$0.04 (1.8%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Cash and cash equivalents
Accounts receivable
Inventory
Other current assets
Total current assets
Fixed assets, net
Intangible assets, net
TOTAL ASSETS
Accounts payable
Accrued expenses
Deferred revenue
Derivative liability
Preferred Dividends Payable
Total current liabilities
Note Payable, maturing July 30, 2027
Total long-term liabilities
TOTAL LIABILITIES
Temporary equity preferred stock (amount)
Common stock value
Common Class A
Common Class B
Total common stock value
Preferred Stock, $0.0001 par value; 5,000,000 shares authorized; 3,911 and 0 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated deficit
Accumulated other Comprehensive Income
TOTAL TEMPORARY EQUITY AND STOCKHOLDERS’ EQUITY
TOTAL LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS' EQUITY

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support